[1]
M. M. Regeda-Furdychko, “Pathogenetic substantiation of thiotriazoline use on the basis of disorders of proteolysis processes and protease inhibitors under conditions of contact dermatitis and experimental pneumonia”, J Educ Health Sport, vol. 9, no. 6, pp. 584–589, Jun. 2019.